FDA Drug recall D-827-2013
DayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuil Sinex NightTime Sinus Relief (ace…
- FDA Drug
- Class II
- terminated
- Published 2013-08-07
On 2013-08-07 the FDA classified a Class II recall of DayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuil Sinex NightTime Sinus Relief (ace… by Procter And Gamble, citing unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the bli….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-827-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-07-03 |
| Published | 2013-08-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Procter And Gamble |
| Distribution | US |
Product
DayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuil Sinex NightTime Sinus Relief (acetaminophen 325 mg, doxylamine succinate 6.25 mg, and phenylephrine HCl 5 mg) liquicaps Combopack, each 48-count liquicaps per carton contains 32 DayQuil Sinex DayTime Liquicaps and 16 NyQuil Sinex NightTime Liquicaps per carton, Made In Canada, Dist. by Procter & Gamble, Cincinnati, OH 45202, UPC 3 23900 01454 1.
Reason
Unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the blisters.
Identifiers
| upc | 323900014541 |
|---|---|
| code_info | Lot # 3051171961, Exp 09/14; Brand Code 84855363 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-827-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.